We quantitatively assessed the levels of FASN and DHCR24 enzymes in melanoma patients and healthy control subjects in relation to plasma TG and CHOL and tested plasma lipid composition by untargeted/targeted lipidomic approaches. This evidence concerns the gene FASN and melanoma.